ArticlePharmacoEconomics - open2024

Cost-Effectiveness of Faricimab in the Treatment of Diabetic Macular Oedema (DMO): A UK Analysis.

Christian Bührer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.